UConn Health opens brain and spine institute
"Discover the new Brain and Spine Institute at UConn Health, offering comprehensive care for neurology, neurosurgery, and spine health. Visit the state-of-the-a
Stay updated with breaking news from Isaac Moss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"Discover the new Brain and Spine Institute at UConn Health, offering comprehensive care for neurology, neurosurgery, and spine health. Visit the state-of-the-a
Researchers hail finding as a ‘huge moment in cystic fibrosis’
Though it is known that drugs like Kalydeco improve cystic fibrosis, the ‘big question’ is if they slow down or prevent decline when started earlier in life, researchers say
In a groundbreaking revelation, a study conducted by RCSI University of Medicine and Health Sciences and Children’s Health Ireland has confirmed the safety and efficacy of a Cystic Fibrosis drug in newborns as young as four weeks old.
A two-year-old Co Meath boy and his sister have played a major role in a new study showing a drug targeting the basic defect that causes cystic fibrosis is safe and effective in newborns aged four weeks and above.